One of the challenge facing the Human Chorionic Gonadotropin (HCG) Market is the potential for misuse and abuse. HCG is sometimes used by athletes and bodybuilders to boost muscle growth and improve athletic performance, despite the fact that such use is not approved by regulatory authorities. This has led to concerns about the potential health risks associated with HCG misuse and abuse.
Global Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at US$ 710.88 Million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030). The human chorionic gonadotropin market is expanding rapidly, driven by various factors such as increasing prevalence of medical conditions that require HCG as part of their treatment, increasing awareness of the benefits of HCG in medical treatments, and the increasing availability of HCG products. However, the market faces challenges such as lack of regulation and potential for misuse and abuse, which must be addressed in order to ensure the continued growth and success of the HCG market.
Explore More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/the-rising-prevalence-of-erectile.html
